These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1210431)

  • 1. [The content of tetanus antitoxins in children's serum].
    Thilo W; Giesecke H; Sowa W; Schmidt J; Cöllen C; Hülsse C; Kaldenbach D
    Z Gesamte Hyg; 1975 Oct; 21(10):775-8. PubMed ID: 1210431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local reactions after repeated tetanus vaccinations].
    Wegmann A; Heiz R
    Schweiz Med Wochenschr; 1979 Oct; 109(38):1409-10. PubMed ID: 531542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetanus antitoxin concentration in the serum of children and adolescents].
    Giesecke H; Baumert A
    Z Gesamte Hyg; 1979 Mar; 25(3):257-60. PubMed ID: 442725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immune status after tetanus vaccination. Possibilities and indications for a quantitative rapid determination of tetanus antibodies in human serum].
    Holzner A
    Fortschr Med; 1978 Apr; 96(13):680-3. PubMed ID: 631708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological response to tetanus toxoid during a schistosomal infection in mice.
    Brito IV; Peel MM; Ree GH
    J Trop Med Hyg; 1976 Jul; 79(7):161-3. PubMed ID: 957465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic reactions in manifest tetanus].
    Möse JR; Dostal V
    Wien Med Wochenschr; 1972 Sep; 122(36):504-7. PubMed ID: 5069545
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination against tetanus and diphtheria. Evaluations of immunity in the Danish population, guidelines for revaccination, and methods for control of vaccination programs.
    Simonsen O
    Dan Med Bull; 1989 Feb; 36(1):24-47. PubMed ID: 2645092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum levels of tetanus antibodies in tetanus patients treated with tetanus antitoxin and toxoid].
    Januszkiewicz J; Galazka A; Adamczyk J; Sporzyńska Z
    Przegl Epidemiol; 1974; 28(2):149-58. PubMed ID: 4849698
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers.
    Sangpetchsong V; Vichaikummart S; Vichitnant A; Podhipak A
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):275-80. PubMed ID: 6523168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of tetanus].
    Sakurai N; Takayama N; Nakayama M; Fujizuka M; Hoshino S
    Nihon Ishikai Zasshi; 1971 Jun; 65(12):1498-505. PubMed ID: 5104687
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T-cell kinetics and course of humoral immune response following subcutaneous immunization with tetanus toxoid fluid vaccine].
    Thilo W; Seeger E; Kraskina NA; Jentsch P; Fritze S; Beinlich R; Fischer R; Sowa W
    Zentralbl Chir; 1983; 108(14):865-74. PubMed ID: 6605009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some remarks on the prevention of tetanus].
    Galazka A
    Wiad Lek; 1967 Dec; 20(24):2185-90. PubMed ID: 5584307
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serological findings following tetanus inoculation].
    Giesecke H; Baumert A
    Z Gesamte Hyg; 1980; 26(10):767-71. PubMed ID: 7467504
    [No Abstract]   [Full Text] [Related]  

  • 15. Active-passive immunization of human subjects against tetanus using homologous gamma globulin.
    Matveev KI; Skurkovich SV; Bychenko BD; Kasparova EM; Konstantinova ND; Minaeva HL
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):246-51. PubMed ID: 4137523
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunization of foals against tetanus toxin. 3. Active immunization of newborn and young foals from specifically pretreated mares].
    Schützler H
    Arch Exp Veterinarmed; 1973; 27(2):251-62. PubMed ID: 4725025
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of allogenic and xenogenic antitoxins in the active-passive prophylaxis of tetanus in an experiment].
    Nazarchuk LV
    Fiziol Zh (1978); 1988; 34(4):98-101. PubMed ID: 3181517
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specific prophylaxis of tetanus].
    Galazka A
    Przegl Epidemiol; 1968; 22(2):157-71. PubMed ID: 5669180
    [No Abstract]   [Full Text] [Related]  

  • 19. Rates of cellular and antibody incorporation of 3H-histidine in mice during secondary responses to tetanus toxoid.
    Stucki M; Hess MW; Cottier H; Hankes LV; Stoner RD
    J Reticuloendothel Soc; 1974 Jun; 15(6):453-65. PubMed ID: 4854033
    [No Abstract]   [Full Text] [Related]  

  • 20. TETANUS AFTER ANTITOXIN PROPHYLAXIS. REPORT OF SIX CASES.
    SHERMAN RT
    Am J Surg; 1964 Jul; 108():36-40. PubMed ID: 14182434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.